iFR Guided PCI to the LAD: Same as for non-LAD Vessels?

iFR has been validated as a useful tool for intermediate lesion analysis, with the advantage of not requiring the use of drugs. On the other hand, its use for PCI outcome assessment has not yet been thoroughly looked into, even though there have been promising data. 

ATC guiada por iFR ¿es igual en la descendente anterior que en el resto de los vasos?

24% of DEFINE PCI cases presented ≤0.89 iFR with a successful angiography. Those reaching ≥0.95 iFR at one year followup, showed lower incidence of cardiovascular mortality, MI, and ischemia driven revascularization. 

One analysis of the DEFINE PCI included the assessment of 506 vessels, 61.5% of the left anterior descending (LAD) and 38.5% to non-LAD vessels (99 left coronary, and 96 circumflex). It excluded cases with two vessels, which included the left main.

Primary end point at 12 months was target vessel failure, defined as a composite of cardiovascular death, MI and ischemia driven target vessel revascularization. 

There were no significant differences in bifurcation presence (4%), length (21.2 mm), stent diameter (3.0 mm) or maximum balloon pressure (18 ATM).

Read also: Can Ultrasound Treat Aortic Stenosis?

Calcified lesions in the LAD were more frequent (43.4% vs. 29.7%, p=0.002), reference vessel diameter was shorter (2.73 mm vs 2.84 mm, p<0.0001) and more post-dilation was required (63.8% vs. 51.5%, p=0.007).

Prior to PCI, LAD iFR was higher (0.82 [0.63, 0.86] vs. 0.72 [0.49, 0.84]; p<0.0001). After PCI, there were no angiographic differences in residual lesion, which was 19%.

Suboptimal iFR (<0.95) was higher in the LAD (77.8% vs 22.6%, p<0.0001). The presence of instent focal residual lesions was higher in the LAD (53.7% vs 27.3%, p=0.0009). There were no differences in primary end point at 12 months between the groups. 

In both groups, improved iFR after PCI was significantly associated with reduced angina and improved quality of life.

Read also: Revascularization vs. Deferral of Physiologically Significant Lesions in the Left Main Coronary Artery.

Independent predictors of low iFR after LAD PCI were age, larger body surface and smaller vessels; while in non-LAD lesions, predictors were calcifications and reference vessel diameter.

Conclusion

In conclusion, after PCI with successful PCI, iFR was lower in LAD lesions vs. non-LAD, which resulted in high prevalence of suboptimal iFR in the LAD. This disparity is attributed in part to a higher frequency of focal residual gradient within the stent segment, that might benefit from a more aggressive PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Changes in post-PCI physiology based on anatomical vessel location: a DEFINE PCI substudy. 

Reference: Mitsuaki Matsumura, et al. EuroIntervention 2023;19-online publish-ahead-of-print November 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...